Skip to content
A guide to studies, with no medical service / 08

What can Sermorelin Medicinal help you understand?

Separate trials measured added height in children and blood hormone amounts in older men. Sermorelin Medicinal explains the results and the questions still unanswered. You're reading a research guide, with no medical team to examine or treat you.

What can you learn by reading Sermorelin Medicinal?

Children gained height faster in one trial; older men had higher blood hormones in another. Adults received tesamorelin for most trials of fat loss and thinking. A result only describes the medicine and people actually tested. Those results don't establish every gain you might hope for in old age.

Sermorelin Medicinal links findings to the published reports behind the numbers. The guide offers no doctor, clinic or pharmacist to see you. The publisher doesn't diagnose, prescribe, mix medicines or supply treatment. Your care needs knowledge of your health beyond those research findings, because a result in another group cannot tell a doctor everything needed to judge treatment for an older person.

Does the Sermorelin name mean a clinic can treat you here?

The word medicinal refers to the subject the researchers studied. Reading about that subject doesn't arrange a medical visit. The guide has no medical staff or pharmacist offering care. You cannot book treatment, receive a prescription or obtain medicine here.

An amount reported from a trial describes what those people received. The same is true of shot type and treatment timing. Those details don't become directions for your health. The publisher provides neither a personal dose nor help obtaining products.

Why can higher Sermorelin blood hormones leave better health unproved?

The children's trial measured added height, a real benefit for those children. Researchers checked the older men's blood for higher amounts of hormone. More hormone doesn't establish stronger muscles or a longer life. Your hoped-for gain needs a test that measures that particular gain.

Adults in the fat and thinking trials received tesamorelin. Similar drug actions don't guarantee the same results from Sermorelin. Brief treatment also leaves safety over many years uncertain. Your possible treatment through old age needs those missing longer-term answers.

Claims about slowing aging reach beyond these trials' findings. Childhood approval doesn't establish an approved treatment for aging adults. Today's pharmacy mixtures differ from the former approved prescription product. A useful health claim needs evidence for the same medicine and health concern.

Does Sermorelin’s pharmacy group mean FDA has proved safety?

2008: Following a business decision, the company ended sales of its approved US prescription product. The decision was commercial, with no finding that the product harmed patients or failed to work. The approved product treated growth problems in children with low growth hormone. That approval doesn't establish treatment for your concerns about aging.

FDA's group 1 means the ingredient remains under review for pharmacy mixing. The group isn't a finding that each mixture is safe or effective. Pharmacies meeting temporary conditions can prepare medicines while that review continues. Drug-tested sports separately ban growth hormone drugs; the sports ban doesn't explain pharmacy safety.